Literature DB >> 3108102

4'-Deoxydoxorubicin (esorubicin) in non-Hodgkin's lymphomas and plasma cell tumors: first evidence of activity.

V Zagonel, U Tirelli, R Sorio, S Frustaci, M A Pacciarini, N Di Pietro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3108102

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  1 in total

1.  Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.

Authors:  Q S Ringenberg; K J Propert; H B Muss; R B Weiss; R L Schilsky; C Modeas; M C Perry; L Norton; M Green
Journal:  Invest New Drugs       Date:  1990-05       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.